Form D · Pharmaceuticals
AZEVAN PHARMACEUTICALS INC
Bethlehem, PA · CIK 0001334514
Offering snapshot reported Oct 18, 2013 · SEC filing
- Reported sold
- $2.21M Offering amount: $6.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Oct 4, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 18, 2013 | Initial | $2,205,000 | No comparison | 4 | SEC filing |
| Mar 12, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 21, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-204832
Source: Form D, filed Oct 18, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Morton Hyman | Director |
| Paul J. Maddon | Director |
| Carter Meyer | Director |
| Mike Pavia | Director |
| Neal G. Simon | Director, Executive |
| Geoffrey Smith | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
116 Research Drive
Bethlehem, PA, 18015
Bethlehem, PA, 18015